NASDAQ: BLSMBlossomhill Therapeutics Inc Stock Ownership - Who owns Blossomhill Therapeutics?
Insider buying vs selling
Have Blossomhill Therapeutics Inc insiders been buying or selling?
Buy
Sell
| Name | Role | Date | Shares | Price | Value |
|---|---|---|---|---|---|
| Bihua Chen | Director | 2026-08-10 | 312,500 | $16.00 | $5.00MBuy |
| Jason A. Keyes | CFO | 2026-08-10 | 700 | $16.00 | $11.20kBuy |
| Vincent Paul Liptak | CLO | 2026-08-10 | 2,200 | $16.00 | $35.20kBuy |
| John P. Schmid | Director | 2026-08-10 | 6,000 | $16.00 | $96.00kBuy |
| Vincent Paul Liptak | CLO | 2026-08-07 | 2,500 | $15.80 | $39.50kBuy |
BLSM insiders have bought more... subscribe to Premium to read more.
Net Insider Buy/Sell (L12M) Ownership
Be the first to know when BLSM insiders and whales buy or sell their stock.
BLSM Shareholders
What type of owners hold Blossomhill Therapeutics Inc stock?
Institutional
Insider
Retail
| Name | Hold | Shares | Value | Type |
|---|---|---|---|---|
| Yishan Li | 13.66% | 3,973,138 | $63.53M | Insider |
| Jingrong Jean Cui | 13.66% | 3,973,138 | $63.53M | Insider |
| Bihua Chen | 12.43% | 3,614,034 | $57.79M | Insider |
| Sundeep Agrawal | 1.99% | 578,524 | $9.25M | Insider |
| Vincent Paul Liptak | 0.46% | 134,099 | $2.14M | Insider |
| Sheila Gujrathi | 0.31% | 90,160 | $1.44M | Insider |
| Geoffrey Raymond Oxnard | 0.06% | 17,785 | $284.38k | Insider |
| John P. Schmid | 0.02% | 6,000 | $95.94k | Insider |
| Jason A. Keyes | 0.00% | 700 | $11.19k | Insider |
Blossomhill Therapeutics Stock Ownership FAQ
Company
AboutNewsBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsPerformanceHelp GuidesContactTwitterYouTubeNewsletterWallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.